Global Patent Index - EP 0533837 A4

EP 0533837 A4 19941117 - INHIBITION OF 5-LIPOXYGENASE AND CYCLOOXYGENASE PATHWAY MEDIATED DISEASES

Title (en)

INHIBITION OF 5-LIPOXYGENASE AND CYCLOOXYGENASE PATHWAY MEDIATED DISEASES

Publication

EP 0533837 A4 19941117 (EN)

Application

EP 91912750 A 19910607

Priority

  • US 53719590 A 19900612
  • US 9104022 W 19910607

Abstract (en)

[origin: WO9119497A1] A method of dual inhibition of 5-lipoxygenase pathway mediated diseases and cyclooxygenase pathway mediated diseases in a subject in need thereof which comprises administering to such subject an effective, non-toxic 5-lipoxygenase pathway inhibiting amount or an effective, non-toxic cyclooxygenase pathway inhibiting amount of a diaryl-substituted imidazole fused to a second unsaturated 5 or 6 membered heterocyclic ring containing a nitrogen bridgehead atom wherein said second 5 membered ring also contains a sulfur or oxygen atom or said 6 membered ring may also contain an additional nitrogen atom.

IPC 1-7

A61K 31/44

IPC 8 full level

A61K 31/435 (2006.01); A61K 31/44 (2006.01); A61K 31/445 (2006.01); A61K 31/505 (2006.01); A61P 43/00 (2006.01); C07D 471/04 (2006.01); C07D 487/04 (2006.01); C07D 498/04 (2006.01); C07D 513/04 (2006.01)

CPC (source: EP KR)

A61K 31/415 (2013.01 - KR); A61K 31/44 (2013.01 - EP); A61K 31/445 (2013.01 - EP); A61P 43/00 (2017.12 - EP)

Citation (search report)

Designated contracting state (EPC)

AT BE CH DE DK ES FR GB GR IT LI LU NL SE

DOCDB simple family (publication)

WO 9119497 A1 19911226; AU 8205991 A 19920107; CA 2084290 A1 19911213; EP 0533837 A1 19930331; EP 0533837 A4 19941117; IE 911977 A1 19911218; JP H05508153 A 19931118; KR 930700104 A 19930313; NZ 238485 A 19940325; PT 97960 A 19920331; ZA 914491 B 19921230

DOCDB simple family (application)

US 9104022 W 19910607; AU 8205991 A 19910607; CA 2084290 A 19910607; EP 91912750 A 19910607; IE 197791 A 19910611; JP 51207791 A 19910607; KR 920703188 A 19921211; NZ 23848591 A 19910611; PT 9796091 A 19910612; ZA 914491 A 19910610